UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis

Antimicrobial agents and chemotherapy, 2021-09, Vol.65 (10), p.e0043421-e0043421

2021

Volltextzugriff (PDF)

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Clinical infectious diseases, 2002-01, Vol.34 (1), p.7-14

2002

Volltextzugriff (PDF)

Efficacy of Olorofim (F901318) against Aspergillus fumigatus , A. nidulans , and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

Clinical infectious diseases, 2003-09, Vol.37 (5), p.634-643

2003

Volltextzugriff (PDF)

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2620-2629

2008

Volltextzugriff (PDF)

Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization

Clinical Microbiology Reviews, 2004-04, Vol.17 (2), p.268-280

2004

Volltextzugriff (PDF)

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Volltextzugriff (PDF)

Amphotericin B: Time for a New “Gold Standard”

Clinical infectious diseases, 2003-08, Vol.37 (3), p.415-425

2003

Volltextzugriff (PDF)

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

European journal of clinical microbiology & infectious diseases, 2007-04, Vol.26 (4), p.271-276

2007

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3142-3146

2009

Volltextzugriff (PDF)

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

European journal of clinical microbiology & infectious diseases, 2005-10, Vol.24 (10), p.654-661

2005

Volltextzugriff (PDF)

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

The Lancet (British edition), 2005-10, Vol.366 (9495), p.1435-1442

2005

Volltextzugriff (PDF)

The Challenge of Antimicrobial Resistance: New Regulatory Tools to Support Product Development

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.166-168

2014

Volltextzugriff (PDF)

Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3133-3137

2012

Volltextzugriff (PDF)

Practice Guidelines for the Treatment of Candidiasis

Clinical infectious diseases, 2000-04, Vol.30 (4), p.662-678

2000

Volltextzugriff (PDF)

In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.245-247

2002

Volltextzugriff (PDF)

Resistance of Candida species to fluconazole

Antimicrobial agents and chemotherapy, 1995, Vol.39 (1), p.1-8

1995

Volltextzugriff (PDF)

European expert opinion on the management of invasive candidiasis in adults

Clinical microbiology and infection, 2011-09, Vol.17, p.1-12

2011

Volltextzugriff (PDF)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Volltextzugriff (PDF)

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

Journal of Clinical Microbiology, 2000-09, Vol.38 (9), p.3457-3459

2000

Volltextzugriff (PDF)

Voriconazole salvage treatment of invasive candidiasis

European journal of clinical microbiology & infectious diseases, 2003-11, Vol.22 (11), p.651-655

2003

Volltextzugriff (PDF)

In vitro susceptibility testing methods for caspofungin against Aspergillus and fusarium isolates

Antimicrobial agents and chemotherapy, 2001, Vol.45 (1), p.327-330

2001

Volltextzugriff (PDF)

Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia

Clinical infectious diseases, 2001-06, Vol.32 (12), p.1713-1717

2001

Volltextzugriff (PDF)

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)

Clinical microbiology and infection, 2003-06, Vol.9 (6), p.467-474

2003

Volltextzugriff (PDF)

1 – 25 von 1.493

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.345)
Mit Volltextzugriff
(1.217)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.468)
Japanisch
(195)
Deutsch
(15)
Russisch
(8)
Französisch
(3)
Koreanisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(955)
Life Sciences & Biomedicine
(734)
Humans
(519)
Biological And Medical Sciences
(356)
Male
(296)
Female
(267)
Medical Sciences
(264)
Animals
(228)
Physical Sciences
(166)
Middle Aged
(134)
Microbiology
(131)
Aged
(119)
Adult
(117)
Fundamental And Applied Biological Sciences. Psychology
(109)
Pharmacology. Drug Treatments
(92)
Infectious Diseases
(91)
Physics
(77)
Mice
(75)
Pharmacology & Pharmacy
(75)
Social Sciences
(73)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

Efficacy of Olorofim (F901318) against Aspergillus fumigatus , A. nidulans , and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease

A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Amphotericin B: Time for a New “Gold Standard”

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

The Challenge of Antimicrobial Resistance: New Regulatory Tools to Support Product Development

Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia

Practice Guidelines for the Treatment of Candidiasis

In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

Resistance of Candida species to fluconazole

European expert opinion on the management of invasive candidiasis in adults

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

Voriconazole salvage treatment of invasive candidiasis

In vitro susceptibility testing methods for caspofungin against Aspergillus and fusarium isolates

Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)

Suchergebnisse filtern